Matinas Biopharma Holdings Inc. (MTNB) NYSE MKT LLC
$0.18 (0) (-0.17%)
Market Cap: $39.54M
As of 04/25/24 04:00 PM EDT. Market closed.
Matinas Biopharma Holdings Inc. (MTNB)
NYSE MKT LLC
$0.18
(0) (-0.17%)
Market Cap: $39.54M
As of 04/25/24 04:00 PM EDT. Market closed.
Add to Portfolio
matinas biopharma (nyse mkt: mtnb) is a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications. the company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable. the company's lead drug candidate ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jerome Jabbour
Full Time Employees
29
CEO Compensation (Base)
$283,750
CEO Compensation (Total)
$560,000
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jerome Jabbour
Full Time Employees
29
CEO Compensation (Base)
$283,750
CEO Compensation (Total)
$560,000
Address
Suite 302, 1545 Route 206 South, New Jersey, Bedminster, 07921.
PRICE CHART FOR MATINAS BIOPHARMA HOLDINGS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.18
Previous Close
$0.18
Days Range
$0.18 - $0.18
52 week range
$0.11 - $0.89
Volume
682,127
Avg. Volume (30 days)
1,819,229
Market Cap
$39.54M
Dividend Yield
-
P/E
(1.72)
Shares Outstanding
217,482,830
Open
$0.18
Previous Close
$0.18
Days Range
$0.18 - $0.18
52 week range
$0.11 - $0.89
Volume
682,127
Avg. Volume (30 days)
1,819,229
Market Cap
$39.54M
Dividend Yield
-
P/E
(1.72)
Shares Outstanding
217,482,830
FINANCIAL STATEMENTS FOR MATINAS BIOPHARMA HOLDINGS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR MATINAS BIOPHARMA HOLDINGS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| STERN ADAM K | Director | Aug 21, 2020 | Buy | $0.83 | 20,000 | 16,600 | 3,301,983 | Aug 24, 2020, 10:00 AM |
| LEPORE PATRICK G | Director | May 14, 2020 | Buy | $0.73 | 100,000 | 73,050 | 400,000 | May 18, 2020, 10:00 AM |
| STERN ADAM K | Director | Apr 03, 2020 | Option Exercise | $0.50 | 278,407 | 139,204 | 1,337,399 | Apr 08, 2020, 04:38 PM |
| STERN ADAM K | Director | Mar 17, 2020 | Buy | $0.65 | 10,000 | 6,500 | 10,000 | Mar 18, 2020, 10:51 AM |
| Jabbour Jerome D | President and CEO | Mar 17, 2020 | Buy | $0.65 | 10,000 | 6,500 | 799,511 | Mar 18, 2020, 10:50 AM |
| Kucinski Keith A | Chief Financial Officer | Nov 25, 2019 | Buy | $1.23 | 58,000 | 71,160 | 94,500 | Nov 26, 2019, 10:00 AM |
| Kucinski Keith A | Chief Financial Officer | Nov 22, 2019 | Buy | $1.20 | 36,500 | 43,807 | 36,500 | Nov 26, 2019, 10:00 AM |
| LEPORE PATRICK G | Director | Nov 15, 2019 | Buy | $1.06 | 100,000 | 105,530 | 300,000 | Nov 19, 2019, 10:00 AM |
| Ende Eric J | Director | Aug 20, 2019 | Buy | $0.66 | 20,000 | 13,200 | 109,292 | Aug 22, 2019, 09:45 AM |
| Jabbour Jerome D | President and CEO | Aug 19, 2019 | Buy | $0.68 | 14,650 | 9,975 | 786,511 | Aug 21, 2019, 09:49 AM |
| Ende Eric J | Director | Aug 19, 2019 | Buy | $0.68 | 20,000 | 13,650 | 89,292 | Aug 21, 2019, 09:47 AM |
| STERN ADAM K | Director | Aug 19, 2019 | Buy | $0.70 | 10,400 | 7,268 | 804,392 | Aug 21, 2019, 09:45 AM |
| LEPORE PATRICK G | Director | Aug 16, 2019 | Buy | $0.72 | 100,000 | 71,850 | 200,000 | Aug 20, 2019, 10:02 AM |
| STERN ADAM K | Director | Jun 14, 2019 | Buy | $0.80 | 15,000 | 12,000 | 3,239,483 | Jun 18, 2019, 10:00 AM |
| Jabbour Jerome D | President and CEO | Jun 12, 2019 | Buy | $0.80 | 12,487 | 9,980 | 771,861 | Jun 13, 2019, 12:53 PM |
| STERN ADAM K | Director | Jun 12, 2019 | Buy | $0.80 | 20,000 | 15,998 | 3,224,483 | Jun 13, 2019, 12:49 PM |
| STERN ADAM K | Director | Jun 10, 2019 | Buy | $0.82 | 15,000 | 12,300 | 3,204,483 | Jun 11, 2019, 05:00 PM |
| STERN ADAM K | Director | Jun 07, 2019 | Buy | $0.89 | 20,000 | 17,800 | 3,189,483 | Jun 10, 2019, 05:00 PM |
| STERN ADAM K | Director | May 31, 2019 | Buy | $0.94 | 80,000 | 75,200 | 3,169,483 | Jun 03, 2019, 05:00 PM |
| STERN ADAM K | Director | May 16, 2019 | Buy | $0.95 | 150,000 | 142,500 | 3,089,483 | May 20, 2019, 06:40 PM |
| LEPORE PATRICK G | Director | May 16, 2019 | Buy | $0.95 | 100,000 | 95,250 | 100,000 | May 20, 2019, 06:39 PM |
| CONRAD HERBERT J | Director | May 16, 2019 | Buy | $0.96 | 25,000 | 24,115 | 172,959 | May 20, 2019, 06:38 PM |
| MANNINO RAPHAEL J | Chief Scientific Officer | Sep 11, 2017 | Buy | $1.41 | 5,000 | 7,050 | 1,424,565 | Sep 15, 2017, 04:18 PM |
| STERN ADAM K | Director | Sep 08, 2017 | Buy | $1.38 | 50,000 | 69,000 | 3,689,483 | Sep 11, 2017, 09:03 AM |
| STERN ADAM K | Director | Sep 07, 2017 | Buy | $1.38 | 50,000 | 69,000 | 3,639,483 | Sep 11, 2017, 09:03 AM |
| Rongen Roelof | Chief Executive Officer | Sep 08, 2017 | Buy | $1.36 | 5,000 | 6,800 | 3,539,416 | Sep 11, 2017, 09:00 AM |
| FERRARI STEFANO | Director | Sep 07, 2017 | Buy | $1.24 | 5,000 | 6,200 | 203,984 | Sep 07, 2017, 05:13 PM |
| CONRAD HERBERT J | Director | Sep 07, 2017 | Buy | $1.30 | 100,000 | 130,000 | 3,879,600 | Sep 07, 2017, 05:06 PM |
| Scibetta James S | Director | Sep 07, 2017 | Buy | $1.29 | 5,000 | 6,450 | 418,309 | Sep 07, 2017, 05:04 PM |
| Lorenzo Jennifer | 10% Owner | Mar 15, 2017 | Option Exercise | $0.75 | 1,369,169 | 1,026,877 | 10,496,760 | Mar 16, 2017, 10:29 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| STERN ADAM K | Director | 08/21/2020 | 16,600 |
| LEPORE PATRICK G | Director | 05/14/2020 | 73,050 |
| STERN ADAM K | Director | 04/03/2020 | 139,204 |
| STERN ADAM K | Director | 03/17/2020 | 6,500 |
| Jabbour Jerome D | President and CEO | 03/17/2020 | 6,500 |
| Kucinski Keith A | Chief Financial Officer | 11/25/2019 | 71,160 |
| Kucinski Keith A | Chief Financial Officer | 11/22/2019 | 43,807 |
| LEPORE PATRICK G | Director | 11/15/2019 | 105,530 |
| Ende Eric J | Director | 08/20/2019 | 13,200 |
| Jabbour Jerome D | President and CEO | 08/19/2019 | 9,975 |
| Ende Eric J | Director | 08/19/2019 | 13,650 |
| STERN ADAM K | Director | 08/19/2019 | 7,268 |
| LEPORE PATRICK G | Director | 08/16/2019 | 71,850 |
| STERN ADAM K | Director | 06/14/2019 | 12,000 |
| Jabbour Jerome D | President and CEO | 06/12/2019 | 9,980 |
| STERN ADAM K | Director | 06/12/2019 | 15,998 |
| STERN ADAM K | Director | 06/10/2019 | 12,300 |
| STERN ADAM K | Director | 06/07/2019 | 17,800 |
| STERN ADAM K | Director | 05/31/2019 | 75,200 |
| STERN ADAM K | Director | 05/16/2019 | 142,500 |
| LEPORE PATRICK G | Director | 05/16/2019 | 95,250 |
| CONRAD HERBERT J | Director | 05/16/2019 | 24,115 |
| MANNINO RAPHAEL J | Chief Scientific Officer | 09/11/2017 | 7,050 |
| STERN ADAM K | Director | 09/08/2017 | 69,000 |
| STERN ADAM K | Director | 09/07/2017 | 69,000 |
| Rongen Roelof | Chief Executive Officer | 09/08/2017 | 6,800 |
| FERRARI STEFANO | Director | 09/07/2017 | 6,200 |
| CONRAD HERBERT J | Director | 09/07/2017 | 130,000 |
| Scibetta James S | Director | 09/07/2017 | 6,450 |
| Lorenzo Jennifer | 10% Owner | 03/15/2017 | 1,026,877 |
Load More Insider Transactions
FUNDS WITH A POSITION IN MATINAS BIOPHARMA HOLDINGS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 2,501,011 | 0.00001% | -0.00972% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,576,513 | 0.00004% | -19.59% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 371,637 | 0.00012% | 73.39% | Other |
CHANGE IN SHARES OUTSTANDING FOR MATINAS BIOPHARMA HOLDINGS INC
STOCK BUYBACKS FOR MATINAS BIOPHARMA HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0%
1Q
06/30/2023
0%
2Q
03/31/2023
0%
3Q
12/31/2022
0.18%
4Q
09/30/2022
0.18%
5Q
06/30/2022
0.18%
6Q
03/31/2022
0.29%
7Q
12/31/2021
0.44%
8Q
09/30/2021
0.97%
9Q
06/30/2021
5.87%
10Q
03/31/2021
6.57%
11Q
12/31/2020
8.98%
12Q
09/30/2020
9.23%
13Q
06/30/2020
9.95%
14Q
03/31/2020
13.35%
15Q
12/31/2019
33.30%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MATINAS BIOPHARMA HOLDINGS INC
LOADING...